A preliminary assessment of the association of SCL-90-R psychological inventory responses with changes in urinary metabolites in patients with chronic fatigue syndrome

Journal of Chronic Fatigue Syndrome

Volumn 3, Issue 1, 1997, Pages 17-37

  McGregor, N R ^a   Dunstan, R H ^b   Butt, H L ^c   Roberts, T K ^b   Klineberg, I J ^a   Zerbes, M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

anxiety aetiology; depression aetiology; Fatigue syndrome chronic aetiology; SCL 90 R; somatization aetiology

Indexed keywords

BETA ALANINE; PYRROLIDINE DERIVATIVE;

ADOLESCENT; ADULT; AMINO ACID URINE LEVEL; ARTICLE; CHRONIC FATIGUE SYNDROME; CLUSTER ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; MULTIPLE REGRESSION; OBSESSION; PHOBIA; PSYCHOLOGIC ASSESSMENT; SOMATIZATION; URINARY EXCRETION;

EID: 0031019961     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v03n01_03     Document Type: Article

References (28)

1. Wilson JC, Walker PJ. Acute anterior poliomyelitis: orthopaedic aspects of the California outbreak of 1934. Arch Intern Med 1936; 57:477-91.
2. McEvedy CP, Beard AW. Royal free epidemic of 1955: a reconsideration. BMJ 1:7-11.
3. Stricklin A, Sewell M, Austad C. Objective measurement of personality variables in epidemic neuromyasthenia patients. S Afr Med J. 1990; 77:31-34.
4. Lane TJ, Manu P, Matthews DA. Depression and somatization in the chronic fatigue syndrome. Am J Med 1991; 91:335-44.
5. Abbey SE, Toner BB, Garfinkel PE, Kennedy SH, Kaplan AS. Self-report symptoms that predict major depression in patients with prominent physical symptoms. Int J Psychiatry Med 1990; 20:247-58.
6. Powell R, Dolan R, Wessely S. Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res 1990; 34:665-73.
7. Wilson A, Hickie I, Lloyd A, et al. Longitudinal study of outcome of chronic fatigue syndrome. BMJ 1994; 308:756-59.
8. Manu P, Matthews DA, Lane TJ. Panic disorder among patients with chronic fatigue. South Med J 1991; 84:451-56.
9. Pepper CM, Krupp B, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci 1993; 5:200-05.
10. DeLuca J, Johnson SK, Natelson BH. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1993; 50:301-04.
11. Smith AP, Behan PO, Bell W, Millar K, Bakheit M. Behavioural problems associated with the chronic fatigue syndrome. Br J Psychol 1993; 84:411-23.
12. McDonald E, Cope H, David A. Cognitive impairment in patients with chronic fatigue: a preliminary study. J Neurol Neurosurg Psychiatry 1993; 56:812-15.
13. Sandman CA, Barron JL, Nackoul K, Goldstein J, Fidler F. Memory deficits associated with chronic fatigue immune dysfunction syndrome. Biol Psychiatry 1993; 33:618-23.
14. Wessely S. The neuropsychiatry of chronic fatigue syndrome. Ciba Found Symp 1993; 173:212-37.
15. Ichise M, Salit IE, Abbey SE, Chung DG, Gray B, Kirsh JC, Freedman M. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992; 13:767-72,
16. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73:1224-34.
17. Bakheit AM, Behan PO, Dinan TG, Gray CE, O'Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992; 304:1010-12.
18. Demitrack MA, Gold PW, Dale JK, Krahn DD, Kling MA, Straus SE. Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. Biol Psychiatry 1992; 32:1065-77.
19. Bakheit AM, Behan PO, Watson WS, Morton JJ. Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. Acta Neurol Scand 1993; 87:234-38.
20. Lieberman J, Bell DS. Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis. Am J Med 1993; 95:407-12.
21. Cleare AJ, Beam J, Allain T, et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Dis 1995; 35:283-89.
22. McGregor NR, Dunstan RH, Zerbes M, Butt HL, Roberts TK, Klineberg IJ. Preliminary determination of a molecular basis to chronic fatigue syndrome. Biochem Molec Med 1996; 57: 73-80.
23. Fukada K, Strauss SE, Hickie I, et al., The chronic fatigue syndrome: a comprehensive approach to its study. Ann Intern Med 1994; 121:953-9.
24. McGregor NR, Dunstan RH, Zerbes M, Butt HL, Roberts TK, Klineberg IJ. Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome. Biochem Molec Med 1996; 58:85-92.
25. Derogatis LR. SCL-90-R administration, scoring and procedures manual-II for the revised version and other instruments of the psychopathology rating scale series. Clinical Psychometrics Research. Towson, MD 21204. 1975.
26. Ray C, Weir WR, Cullen S, Phillips S. Illness perception and symptom components in chronic fatigue syndrome. J Psychosom Res. 1992; 36:243-56.
27. Samuels AH. Somatization disorder: a major public health issue. Med J Aust 1995; 163:147-49.
28. Goodnick PJ, Sandoval R, Brickman A, Klimas NG. Bupropion treatment of fluoxetine-resislant chronic fatigue syndrome. Biol Psychiatry 1992; 32:834-38.